Continued strong Cresemba® (isavuconazole) sales

Continued strong Cresemba® (isavuconazole) sales

Basel/Allschwil, Switzerland, February 07, 2023 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting......

menu
menu